TEPADINA
THIOTEPA
- Strength
- 100 mg/1
- Form
- Injection, Powder, For Solution
- Class
- Alkylating Drug
Amneal Pharmaceuticals LLC
thiotepa
Listed by Shorla Oncology Inc.
| Dosage form | Injection |
|---|---|
| Route | Intravenous |
| Drug class | Alkylating Drug |
| Approval route | NDA — original brand approval |
| NDC code | 81927-105 |
| FDA application | NDA216984 |
| RxNorm concept | 2700709 |
| Package sizes listed | 1 |
| Marketed since | March 2025 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
THIOTEPA
Amneal Pharmaceuticals LLC
thiotepa
Amneal Pharmaceuticals LLC
THIOTEPA
Amneal Pharmaceuticals LLC
thiotepa
Amneal Pharmaceuticals LLC
thiotepa
Shorla Oncology Inc.
Novadoz Pharmaceuticals LLC
Meitheal Pharmaceuticals Inc
Sagent Pharmaceuticals
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.